1. Home
  2. BNR vs BKT Comparison

BNR vs BKT Comparison

Compare BNR & BKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$23.40

Market Cap

216.9M

Sector

Health Care

ML Signal

HOLD

Logo BlackRock Income Trust Inc. (The)

BKT

BlackRock Income Trust Inc. (The)

HOLD

Current Price

$11.07

Market Cap

245.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
BKT
Founded
2014
1988
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
216.9M
245.7M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
BKT
Price
$23.40
$11.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
54.2K
67.9K
Earning Date
11-20-2025
01-01-0001
Dividend Yield
N/A
8.97%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$75,749,382.00
N/A
Revenue This Year
$136.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.56
N/A
52 Week Low
$2.18
$10.55
52 Week High
$24.92
$12.92

Technical Indicators

Market Signals
Indicator
BNR
BKT
Relative Strength Index (RSI) 58.13 51.71
Support Level $19.10 $11.03
Resistance Level $24.92 $11.10
Average True Range (ATR) 2.36 0.06
MACD -0.02 0.01
Stochastic Oscillator 67.01 73.33

Price Performance

Historical Comparison
BNR
BKT

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About BKT BlackRock Income Trust Inc. (The)

Blackrock Income Trust Inc is a diversified investment fund with an investment objective to manage a portfolio of high-quality securities to achieve both preservations of capital and high monthly income. The trust seeks to achieve its investment objective by investing at least 65 percent of its assets in mortgage-backed securities. The Fund invests at least 80 percent of its assets in securities that are (i) issued or guaranteed by the U.S. government or one of its agencies or instrumentalities or (ii) rated at the time of investment either AAA by S&P Global Ratings (S&P) or Aaa by Moody's Investors Service, Inc (Moody's). The Fund may invest directly in such securities or synthetically through the use of derivatives.

Share on Social Networks: